trial · primary record
Metformin
Menopause
| Phase | Phase 2, Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 200 |
| Primary completion | 2030-10-01 |
| Primary endpoint | Epigenetic aging measurements of "PhenoAge" |
| Registry ID | NCT06975111 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:59:24.420Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06975111
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Metformin · compound